Stem cell therapies and regenerative medicine in China

Science China Life Sciences

Volumn 57, Issue 2, 2014, Pages 157-161

  Huang, Sha ^a,b   Fu, XiaoBing ^a  

^a CHINESE PLA GENERAL HOSPITAL   (China)

^b Hainan Branch of General Hospital of PLA   (China)

Author keywords

clinical trial; regenerative medicine; stem cells; tissue engineering

Indexed keywords

CHINA; CLINICAL TRIAL (TOPIC); CYTOLOGY; HUMAN; MEDICAL RESEARCH; REGENERATIVE MEDICINE; REVIEW; STEM CELL;

BIOMEDICAL RESEARCH; CHINA; CLINICAL TRIALS AS TOPIC; HUMANS; REGENERATIVE MEDICINE; STEM CELLS;

EID: 84893723499     PISSN: 16747305     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11427-014-4608-3     Document Type: Review

References (36)

1. Longstaff H, Khramova V, Eijkholt M, Mizgalewicz A, Illes J. Hopes and fears for professional movement in the stem cell community. Cell Stem Cell, 2013, 12: 517-519.
2. Jin X, Zheng L, Zheng RH, Li YM. China's policies on stem cell research: an opportunity for international collaborations. Nat Rev Mol Cell Biol, 2009, 10: 286.
3. Chen SL, Fang WW, Ye F, Liu YH, Qian J, Shan SJ, Zhang JJ, Chunhua RZ, Liao LM, Lin S, Sun JP. Effect on left ventricular function of intracoronary transplantation of autologous bone marrow mesenchymal stem cell in patients with acute myocardial infarction. Am J Cardiol, 2004, 94: 92-95.
4. Sheng Z, Fu X, Cai S, Lei Y, Sun T, Bai X, Chen M. Regeneration of functional sweat gland-like structures by transplanted differentiated bone marrow mesenchymal stem cells. Wound Repair Regen, 2009, 17: 427-435.
5. Li Q, Zhou X, Shi Y, Li J, Zheng L, Cui L, Zhang J, Wang L, Han Z, Han Y, Fan D. In vivo tracking and comparison of the therapeutic effects of MSCs and HSCs for liver injury. PLoS ONE, 2013, 8: e62363.
6. Li L, Zhang Y, Li Y, Yu B, Xu Y, Zhao S, Guan Z. Mesenchymal stem cell transplantation attenuates cardiac fibrosis associated with isoproterenol-induced global heart failure. Transpl Int, 2008, 21: 1181-1189.
7. Jiang R, Han Z, Zhuo G, Qu X, Li X, Wang X, Shao Y, Yang S, Han ZC. Transplantation of placenta-derived mesenchymal stem cells in type 2 diabetes: a pilot study. Front Med, 2011, 5: 94-100.
8. Peng L, Xie DY, Lin BL, Liu J, Zhu HP, Xie C, Zheng YB, Gao ZL. Autologous bone marrow mesenchymal stem cell transplantation in liver failure patients caused by hepatitis B: short-term and long-term outcomes. Hepatology, 2011, 54: 820-828.
9. Halme DG, Kessler DA. FDA regulation of stem-cell-based therapies. N Engl J Med, 2006, 355: 1730-1735.
10. Daley GQ. The promise and perils of stem cell therapeutics. Cell Stem Cell, 2012, 10: 740-749.
11. Clements WK, Traver D. Signalling pathways that control vertebrate haematopoietic stem cell specification. Nat Rev Immunol, 2013, 13: 336-348.
12. Leventhal J, Miller J, Abecassis M, Tollerud DJ, Ildstad ST. Evolving approaches of hematopoietic stem cell-based therapies to induce tolerance to organ transplants: the long road to tolerance. Clin Pharmacol Ther, 2013, 93: 36-45.
13. Thomas ED. Bone marrow transplantation from the personal viewpoint. Int J Hematol, 2005, 81: 89-93.
14. Griffin M, Iqbal SA, Bayat A. Exploring the application of mesenchymal stem cells in bone repair and regeneration. J Bone Joint Surg Br, 2011, 93: 427-434.
15. Wen Z, Zheng S, Zhou C, Wang J, Wang T. Repair mechanisms of bone marrow mesenchymal stem cells in myocardial infarction. J Cell Mol Med, 2011, 15: 1032-1043.
16. Gnecchi M, Zhang Z, Ni A, Dzau VJ. Paracrine mechanisms in adult stem cell signaling and therapy. Circ Res, 2008, 103: 1204-1219.
17. Menasche P. Cardiac cell therapy: lessons from clinical trials. J Mol Cell Cardiol, 2011, 50: 258-265.
18. Williams AR, Trachtenberg B, Velazquez DL, McNiece I, Altman P, Rouy D, Mendizabal AM, Pattany PM, Lopera GA, Fishman J, Zambrano JP, Heldman AW, Hare JM. Intramyocardial stem cell injection in patients with ischemic cardiomyopathy: functional recovery and reverse remodeling. Circ Res, 2011, 108: 792-796.
19. Ogawa M, LaRue AC, Mehrotra M. Hematopoietic stem cells are pluripotent and not just "hematopoietic". Blood Cells Mol Dis, 2013, 51: 3-8.
20. Rocha V, Labopin M, Sanz G, Arcese W, Schwerdtfeger R, Bosi A, Jacobsen N, Ruutu T, de Lima M, Finke J, Frassoni F, Gluckman E. Acute Leukemia Working Party of European Blood and Marrow Transplant Group; Eurocord-Netcord Registry. Transplants of umbilicalcord blood or bone marrow from unrelated donors in adults with acute leukemia. N Engl J Med, 2004, 351: 2276-2285.
21. Copeland N, Harris D, Gaballa MA. Human umbilical cord blood stem cells, myocardial infarction and stroke. Clin Med, 2009, 9: 342-345.
22. Harris DT. Non-haematological uses of cord blood stem cells. Br J Haematol, 2009, 147: 177-184.
23. McKenna D, Sheth J. Umbilical cord blood: current status & promise for the future. Indian J Med Res, 2011, 134: 261-269.
24. Prasad VK, Kurtzberg J. Umbilical cord blood transplantation for non-malignant diseases. Bone Marrow Transplant, 2009, 44: 643-651.
25. Trounson A, Thakar RG, Lomax G, Gibbons D. Clinical trials for stem cell therapies. BMC Med, 2011, 9: 52.
26. Taylor CJ, Bolton EM, Bradley JA. Immunological considerations for embryonic and induced pluripotent stem cell banking. Philos Trans R SocLond B Biol Sci, 2011, 366: 2312-2322.
27. Schwartz SD, Hubschman JP, Heilwell G, Franco-Cardenas V, Pan CK, Ostrick RM, Mickunas E, Gay R, Klimanskaya I, Lanza R. Embryonic stem cell trials for macular degeneration: a preliminary report. Lancet, 2012, 379: 713-720.
28. Wilson JM. Medicine. A history lesson for stem cells. Science, 2009, 324: 727-728.
29. Lutolf MP, Gilbert PM, Blau HM. Designing materials to direct stem-cell fate. Nature, 2009, 462: 433-441.
30. Mooney DJ, Vandenburgh H. Cell delivery mechanisms for tissue repair. Cell Stem Cell, 2008, 2: 205-213.
31. Trounson A, DeWitt ND, Feigal EG. The Alpha Stem Cell Clinic: a model for evaluating and delivering stem cell-based therapies. Stem Cells Transl Med, 2012, 1: 9-14.
32. Weissman I. Stem cell therapies could change medicine... if they get the chance. Cell Stem Cell, 2012, 10: 663-665.
33. Bianco P, Barker R, Brüstle O, Cattaneo E, Clevers H, Daley GQ, De Luca M, Goldstein L, Lindvall O, Mummery C, Robey PG, Sattler de Sousa E, Brito C, Smith A. Regulation of stem cell therapies under attack in Europe: for whom the bell tolls. EMBO J, 2013, 32: 1489-1495.
34. von Tigerstrom B. Product regulation and the clinical translation of stem cell research. Stem Cell Rev, 2009, 5: 135-139.
35. Zarzeczny A, Caulfield T. Stem cell tourism and doctors' duties to minors-a view from Canada. Am J Bioeth, 2010, 10: 3-15.
36. Hyun I, Lindvall O, Ahrlund-Richter L, Cattaneo E, Cavazzana-Calvo M, Cossu G, De Luca M, Fox IJ, Gerstle C, Goldstein RA, Hermerén G, High KA, Kim HO, Lee HP, Levy-Lahad E, Li L, Lo B, Marshak DR, McNab A, Munsie M, Nakauchi H, Rao M, Rooke HM, Valles CS, Srivastava A, Sugarman J, Taylor PL, Veiga A, Wong AL, Zoloth L, Daley GQ. New ISSCR guidelines underscore major principles for responsible translational stem cell research. Cell Stem Cell, 2008, 3: 607-609.